C. Couteau
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Oncology top 1%
- Cancer Treatment and Pharmacology 10
- Colorectal Cancer Treatments and Studies 5
- Neutropenia and Cancer Infections 4
- Cancer survivorship and care 2
-
- Lung Cancer Treatments and Mutations 3
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies 3
-
- Cancer therapeutics and mechanisms 5
C. Couteau
19 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Hepatology 1.0k
- Oncology 2.5k
- Pulmonary and Respiratory Medicine 965
- Otorhinolaryngology 106
- Pathology and Forensic Medicine 304
Countries citing papers authored by C. Couteau
This map shows the geographic impact of C. Couteau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Couteau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Couteau more than expected).
Fields of papers citing papers by C. Couteau
This network shows the impact of papers produced by C. Couteau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Couteau. The network helps show where C. Couteau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Couteau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2019 | 27 | |
| 3 | 2018 | 11 | |
| 4 | 2004 | 31 | |
| 5 | 2004 | 3 | |
| 6 | 2004 | 1 | |
| 7 | FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Studybreakdown → | 2003 | 2290 |
| 8 | 2002 | 40 | |
| 9 | 2001 | 6 | |
| 10 | 2000 | 36 | |
| 11 | 1999 | 47 | |
| 12 | 1999 | 222 | |
| 13 | 1999 | 69 | |
| 14 | 1997 | 3 | |
| 15 | CPT-11: the European clinical development. | 1996 | 2 |
| 16 | 1996 | 19 | |
| 17 | [Taxotere (docetaxel) and CPT 11 (irinotecan): phase I trials]. | 1996 | 1 |
| 18 | 1995 | 11 | |
| 19 | [Chemotherapy in the treatment of brain metastases of breast cancers]. | 1994 | 2 |
About C. Couteau
C. Couteau is a scholar working on Otorhinolaryngology, Oncology, Hepatology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Cancer therapeutics and mechanisms (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Neutropenia and Cancer Infections (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Head and Neck Cancer Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer survivorship and care (2 papers). The work is most often cited by research in Hepatology (1.0k citations), Oncology (2.5k citations), Pulmonary and Respiratory Medicine (965 citations), Otorhinolaryngology (106 citations) and Pathology and Forensic Medicine (304 citations). C. Couteau has collaborated with scholars based in France, Belgium and Canada. Frequent co-authors include Thierry André, Christophe Louvet, Aimery de Gramont, G. Ganem, Emmanuel Achille, Christophe Tournigand, Gérard Lledo, Philippe Colin, Bruno Landi and Emmanuel Quinaux. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Cancer, British Journal of Cancer and The Journal of Sexual Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.